Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
OmniAb
Emeryville, California, United Statesomniab.com ↗
- Ownership
- Public · OABI
- Employees
- ~114
- Development stage
- Commercial
01
Overview
OmniAb provides industry-leading transgenic animal-based platforms and AI-powered technologies to enable pharmaceutical partners to discover fully human antibodies and other next-generation biologics. Its technologies are widely adopted by over 90 biopharma companies globally. Clinical results pertain to partner programs using the platform rather than direct development by OmniAb itself.
- Therapeutic areas
- OncologyImmunologyNeurologyInfectious Diseases
- Modalities
- Monoclonal antibodyBispecific monoclonal antibodyAntibody-drug conjugateCAR-T cell therapyTargeted radiopharmaceuticalSingle domain antibody (nanobody)
- Industry
- Drug Discovery Services
02
Partnerships
Over 90 biopharmaceutical companies and research institutions worldwide license or collaborate with OmniAb for their drug discovery effortsPartnership with mAbsolve Ltd. for Fc-silencing STR technology integration into antibodies generated via the platformExtensive network of CROs experienced in characterization/bioinformatics/cell line development/GMP manufacturing using its technologies
03
Financials
- Market cap
- $582.1M
- Total revenue
- $13.4M
- Enterprise value
- $549M
Beyond the preview
Go deeper on OmniAb.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on OmniAb.